Connect with us

Hi, what are you looking for?

Tuesday, Mar 31, 2026

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "Breath Diagnostics"

Eli Lilly inks USD$2.75B AI drug deal with Insilico Medicine

Eli Lilly inks USD$2.75B AI drug deal with Insilico Medicine

Medical and Pharmaceutical

Eli Lilly inks USD$2.75B AI drug deal with Insilico Medicine

Insilico has developed at least 28 drug candidates using generative AI tools

Joseph Morton2 hours ago

bioAffinity Technologies soars on Monday as non-invasive lung cancer tech gains traction

bioAffinity Technologies soars on Monday as non-invasive lung cancer tech gains traction

Medical and Pharmaceutical

bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction

Shares rose by 73% during the session with no immediate catalyst

Rowan DunneMarch 23, 2026

Bacterial infection breath test demonstrates efficacy in rodent studies

Bacterial infection breath test demonstrates efficacy in rodent studies

Medical and Pharmaceutical

Bacterial infection breath test demonstrates efficacy in rodent studies

It can provide results within 10 minutes

Rowan DunneMarch 18, 2026

Guardant Health launches multi-cancer blood test in Asia through Manulife partnership

Guardant Health launches multi-cancer blood test in Asia through Manulife partnership

Medical and Pharmaceutical

Guardant Health launches multi-cancer blood test in Asia through Manulife partnership

Cancer remains a leading cause of death across Asia, driving demand for early screening tools

Joseph MortonMarch 18, 2026

Monash University's medical engineering institute develops silicosis breath test

Monash University's medical engineering institute develops silicosis breath test

Medical and Pharmaceutical

Monash University’s medical engineering institute progresses silicosis breath test

Its MedTech Commercialisation Advancement Program has been expediting the tool's development

Rowan DunneMarch 9, 2026

Optellum breaks new ground with TGA approval for AI-powered lung nodule solution

Optellum breaks new ground with TGA approval for AI-powered lung nodule solution

Medical and Pharmaceutical

Optellum breaks new ground with TGA approval for AI-powered lung nodule solution

'Radiological computer-assisted diagnostic software for lesions suspicious of cancer' is what the FDA calls it

Rowan DunneMarch 5, 2026

Minnesota companies Vocxi Health and Forj Medical team up on lung cancer breath test

Minnesota companies Vocxi Health and Forj Medical team up on lung cancer breath test

Medical and Pharmaceutical

Minnesota’s Vocxi Health and Forj Medical report success with lung cancer breath test

It uses nanosensors and AI algorithms to detect volatile organic compounds linked to the disease

Rowan DunneMarch 3, 2026

Tempus AI builds on FDA win with Median partnership for lung cancer detection

Tempus AI builds on FDA win with Median partnership for lung cancer detection

Medical and Pharmaceutical

Tempus AI builds on FDA win with Median partnership for lung cancer detection

Median secured FDA 510(k) approval for eyonis LCS on Feb. 9

Rowan DunneFebruary 23, 2026

Breath Diagnostics advances pre-op pneumonia screening with FDA breakthrough designation

Breath Diagnostics advances pre-op pneumonia screening with FDA breakthrough designation

Medical and Pharmaceutical

Breath Diagnostics advances pre-op pneumonia screening with FDA breakthrough designation

The FDA grants Breakthrough Device status to a limited group of technologies

Joseph MortonFebruary 19, 2026

Biotech operator Personalis sees 10% spike from Medicare covering lung cancer test

Biotech operator Personalis sees 10% spike from Medicare covering lung cancer test

Medical and Pharmaceutical

Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test

The ctDNA blood draw is known for its ultrasensitive detection capabilities

Rowan DunneFebruary 10, 2026

More Posts

Page 1 of 1512 3 4 5 Next ›Last »